EUVIMEDSkopri EUVIMED
Crossref

Design, Synthesis, and Evaluation of Halo‐Substituted Flavonols Against Melanoma A375 Cells

Tzu-Yun Sheng, Kuan-Ying Huang iD, Yu-Jui Su, Sin-Min Li iD, Tiffany Tze-Jun Luh, Ting-Yu Tsai, Sy-Chyi Cheng, Jih-Jung Chen, Tzenge-Lien Shih iD

ChemMedChem · 2026-10-28 · 21 (20)

DOI: 10.1002/cmdc.70549 ↗

At a glance

Journal article in ChemMedChem, published online on 2026-10-25. Written by Tzu-Yun Sheng and 8 co-authors. Institution: Department of Chemistry, Tamkang University, New Taipei City, Taiwan, ROC. Major MEDLINE topics: Flavonols, Antineoplastic Agents, Drug Design, Melanoma. 27 references. Funded by: National Science and Technology Council.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Malignant melanoma is one of the most aggressive forms of skin cancer. Despite advances in targeted therapy and immunotherapy, the emergence of drug resistance and limited therapeutic efficacy in advanced stages remain major clinical challenges. In this study, a series of novel flavonols were synthesized and evaluated for their cytotoxic activity against human malignant melanoma A375 cells. Among the tested compounds, compound 4j exhibited the most potent inhibitory effect, with an IC 50 value of 25.07 ± 2.24 μM, outperforming 5‐fluorouracil (5‐FU) used as a positive control. Furthermore, Western blot analysis revealed that compound 4j modulated the expression of key apoptotic regulators: it downregulated the anti‐apoptotic protein Bcl‐2, upregulated the pro‐apoptotic protein Bax, and activated caspase‐3, indicating induction of apoptosis via a caspase‐dependent mitochondrial pathway. Molecular docking analysis further showed that the halogenated derivatives exhibited distinct interaction patterns within the Bcl‐2 binding groove, supporting the observed positional structure–activity relationship. These findings demonstrate that compound 4j possesses promising anticancer activity against malignant melanoma cells. They support flavonols as valuable scaffolds for the development of new anti‐melanoma agents, with compound 4j emerging as a particularly compelling lead candidate.

Subjects

MeSH terms (MEDLINE)

FlavonolsAntineoplastic AgentsDrug DesignMelanomaHumansStructure-Activity RelationshipDrug Screening Assays, AntitumorCell Line, TumorMolecular Docking SimulationApoptosisCell ProliferationProto-Oncogene Proteins c-bcl-2Molecular StructureDose-Response Relationship, Drug

Author keywords

anticancerhalo‐substituent flavonolhuman malignant melanoma

Substances

FlavonolsAntineoplastic AgentsProto-Oncogene Proteins c-bcl-2

Authors and institutions

  • Department of Chemistry, Tamkang University, New Taipei City, Taiwan, ROC.
  • Department of Pharmacy, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC.
  • School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC.
  • Academia Sinica Biotechnology Center in Southern Taiwan, Tainan, Taiwan, ROC.
  • Agricultural Biotechnology Research Center, Taipei, Taiwan, ROC.
  • Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan, ROC.

ORCID profiles: Kuan-Ying Huang, Sin-Min Li, Tzenge-Lien Shih

Funding

  • National Science and Technology Council

Cite

APA

Sheng, T. Y., Huang, K. Y., Su, Y. J., Li, S. M., Luh, T. T., Tsai, T. Y., Cheng, S. C., Chen, J. J., & Shih, T. L. (2026). Design, Synthesis, and Evaluation of Halo‐Substituted Flavonols Against Melanoma A375 Cells. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70549

Vancouver

Sheng TY, Huang KY, Su YJ, Li SM, Luh TT, Tsai TY, et al. Design, Synthesis, and Evaluation of Halo‐Substituted Flavonols Against Melanoma A375 Cells. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70549

BibTeX
@article{Sheng2026,
  author = {Sheng, Tzu-Yun and Huang, Kuan-Ying and Su, Yu-Jui and Li, Sin-Min and Luh, Tiffany Tze-Jun and Tsai, Ting-Yu and Cheng, Sy-Chyi and Chen, Jih-Jung and Shih, Tzenge-Lien},
  title = {Design, Synthesis, and Evaluation of Halo‐Substituted Flavonols Against Melanoma A375 Cells},
  journal = {ChemMedChem},
  year = {2026},
  volume = {21},
  number = {20},
  doi = {10.1002/cmdc.70549}
}
Start for free →